Latest News and Press Releases

New York City, NY, March 27, 2026 (GLOBE NEWSWIRE) -- Something interesting is happening in the way Americans deal with foot pain. Instead of booking another $250 podiatrist appointment or...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...

NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in

Vera Therapeutics announces inducement grants Under Nasdaq Listing Rule 5635(c)(4).

BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...

Did you buy GEMI Class A common stock and/or securities between September 12, 2025, and February 17, 2026? Affected GEMI Investor Summary Who: Gemini Space Station, Inc. (NASDAQ: GEMI)What:...

The Prince Collection is highly regarded for its royal association, conferring distinguished provenance upon selected lots.

Draft agenda and draft decisions for the Annual General Meeting of Telia Lietuva, AB (hereinafter ‘the Company’ or ‘Telia Lietuva’) shareholders to be held on 24 April 2026 proposed by the Board of...

The Annual General Meeting of Telia Lietuva, AB (code 121215434, registered address: Saltoniškių str. 7A, Vilnius, Lithuania) Shareholders will be held in Telia Lietuva, AB headquarters, Saltoniškių...

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Trip.com Group Limited (NASDAQ: TCOM) between April 30,...